TCIM
RCKT icon

TIAA CREF Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History

TIAA CREF Investment Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$736K Hold
41,963
– – ﹤0.01% 2444
2018
Q4 		$622K Sell
41,963
-378
-0.9% -$6.28K ﹤0.01% 2476
2018
Q3 		$1.04M Sell
42,341
-4,024
-9% -$87.3K ﹤0.01% 2404
2018
Q2 		$910K Buy
+46,365
New +$877K ﹤0.01% 2535
2017
Q2 		– Sell
-13,981
Closed -$112K – 3166
2017
Q1 		$112K Hold
13,981
– – ﹤0.01% 3035
2016
Q4 		$341K Buy
13,981
+1,283
+10% +$36.6K ﹤0.01% 2948
2016
Q3 		$482 Hold
12,698
– – ﹤0.01% 2857
2016
Q2 		$378K Buy
+12,698
New +$446K ﹤0.01% 2971

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return